Carotid Reconstruction for Ocular Ischemic Syndrome Can We Predict the Visual Outcome?

Author:

Ino-ue Masanori,Yamamoto Misao1,Asada Masahiro,Tamaki Norihiko2

Affiliation:

1. Department of Ophthalmology, Kobe University, School of Medicine, Kobe, Japan

2. Department of Neurosurgery, Kobe University, School of Medicine, Kobe, Japan

Abstract

Ocular ischemic syndrome is a progressive disorder that results from ocular ischemia in occlusive diseases of the carotid system. Ocular manifestations of 16 patients with ocular ischemic syndrome were evaluated retrospectively before and after carotid artery surgery. Although carotid endarterectomy (CEA) and carotid bypass surgery were beneficial to stabilize the ocular manifestations of nine eyes with amaurosis fugax and hypoperfusion retinopathy, ipsilateral blindness due to retinal artery occlusion developed following CEA in one eye. Conversely, carotid artery surgery in ocular ischemic syndrome with iris neovascularization has not been successful in stabilizing the ocular manifestations. As expected, carotid bypass surgery did not resolve neovascular glaucoma due to iris neovascularization in two eyes and was followed by an elevation of normal intraocular pressure in one eye. One eye with iris neovascularization developed an intractable glaucoma following CEA. The presence of iris neovascularization suggests poor visual prognosis after carotid artery surgery. The development of retinal artery occlusion and secondary glaucoma after CEA should be listed as postoperative ocular complications of carotid artery surgery. In conclusion, carotid artery surgery is effective for ocular ischemic syndrome before the onset of iris neovascularization. Presence of iris neovascularization needs careful indication of carotid artery surgery to prevent the elevation of intraocular pressure.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3